Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0.00743548622248149 0.00743548622248149
Stock impact report

How The FDA's Decision On Aducanumab May Affect The Value Of Biogen's Stock [Seeking Alpha]

EISAI CO S/ADR (ESALY) 
NASDAQ:AMEX Investor Relations: eisai.com/ir/index.html
Company Research Source: Seeking Alpha
In November 2019, Biogen’s (BIIBI don’t think the field has ever seen data like this,' said Sandrock … Sandrock didn’t offer a prediction, but if the FDA rejects the drug now or asks Biogen to conduct another large clinical trial to collect additional data, it would mean ‘lots more people’ would get Alzheimer’s without a drug to help them (source of quoteBut Sandrock appears reluctant to release even subgroup analysis and probably with good reason as he likely knows this data would make FDA approval far more problematical(reluctanceBiogen is no paper tiger. It has plenty of human and financial resources (a net operating cash flow of over 7 billion dollars as of 2019). It is one of the foremost pharmaceutical companies studying neurological diseases and conditions. And most stock analysts consider the company to be undervalued. Yet none of this will matter if the FDA rejects Biogen’s application for aducanumab.A close analysis of the results presented by Biogen for aducanumab indicates Show less Read more
Impact Snapshot
Event Time:
ESALY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ESALY alerts
Opt-in for
ESALY alerts

from News Quantified
Opt-in for
ESALY alerts

from News Quantified